Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Normal organ radiation dosimetry and associated uncertainties in nuclear medicine, with emphasis on iodine-131.

Brill AB, Stabin M, Bouville A, Ron E.

Radiat Res. 2006 Jul;166(1 Pt 2):128-40.

PMID:
16808602
2.

Uncertainties in dose coefficients from ingestion of 131I, 137Cs, and 90Sr.

Apostoaei AI, Miller LF.

Health Phys. 2004 May;86(5):460-82.

PMID:
15083142
3.

Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.

Nieuwlaat WA, Hermus AR, Ross HA, Buijs WC, Edelbroek MA, Bus JW, Corstens FH, Huysmans DA.

J Nucl Med. 2004 Apr;45(4):626-33.

5.

A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.

Boice JD Jr, Leggett RW, Ellis ED, Wallace PW, Mumma M, Cohen SS, Brill AB, Chadda B, Boecker BB, Yoder RC, Eckerman KF.

Health Phys. 2006 May;90(5):409-30.

PMID:
16607174
6.

Questionnaire- and measurement-based individual thyroid doses in Ukraine resulting from the Chornobyl nuclear reactor accident.

Likhtarev I, Bouville A, Kovgan L, Luckyanov N, Voillequé P, Chepurny M.

Radiat Res. 2006 Jul;166(1 Pt 2):271-86.

PMID:
16808613
7.
8.

Thyroid uptake and radiation dose after (131)I-lipiodol treatment: is thyroid blocking by potassium iodide necessary?

Bacher K, Brans B, Monsieurs M, De Winter F, Dierckx RA, Thierens H.

Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1311-6. Epub 2002 Jul 31.

PMID:
12271412
9.

A modified ICRP 66 iodine gas uptake model and its parametric uncertainty.

Harvey RP, Hamby DM, Palmer TS; International Commision on Radiological Protection..

Health Phys. 2004 Nov;87(5):490-506.

PMID:
15551787
11.

NRC absorbed dose reconstruction for family member of 131I therapy patient: case study and commentary.

Marcus CS, Siegel JA.

J Nucl Med. 2004 Apr;45(4):13N-6N, 37N. No abstract available.

12.

Post-Chornobyl thyroid cancers in Ukraine. Report 1: estimation of thyroid doses.

Likhtarov I, Kovgan L, Vavilov S, Chepurny M, Bouville A, Luckyanov N, Jacob P, Voillequé P, Voigt G.

Radiat Res. 2005 Feb;163(2):125-36.

PMID:
15658887
13.

Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients.

Canzi C, Zito F, Voltini F, Reschini E, Gerundini P.

Med Phys. 2006 Aug;33(8):2860-7.

PMID:
16964862
15.

Radiopharmaceuticals for nuclear cardiology: radiation dosimetry, uncertainties, and risk.

Stabin MG.

J Nucl Med. 2008 Sep;49(9):1555-63. doi: 10.2967/jnumed.108.052241.

16.

A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.

Konijnenberg MW, Bijster M, Krenning EP, De Jong M.

J Nucl Med. 2004 Jul;45(7):1260-9. Erratum in: J Nucl Med. 2009 Dec;50(12):2092.

17.

Evaluation of the potential absorbed doses from patients based on whole-body 131I clearance in thyroid cancer therapy.

Willegaignon J, Stabin MG, Guimarães MI, Malvestiti LF, Sapienza MT, Maroni M, Sordi GM.

Health Phys. 2006 Aug;91(2):123-7.

PMID:
16832193
18.

Dosimetry of radioiodine for embryo and fetus.

Berkovski V, Eckerman KF, Phipps AW, Nosske D.

Radiat Prot Dosimetry. 2003;105(1-4):265-8.

PMID:
14526968
19.

Organ Dose Estimates for Hyperthyroid Patients Treated with (131)I: An Update of the Thyrotoxicosis Follow-Up Study.

Melo DR, Brill AB, Zanzonico P, Vicini P, Moroz B, Kwon D, Lamart S, Brenner A, Bouville A, Simon SL.

Radiat Res. 2015 Dec;184(6):595-610. doi: 10.1667/RR14160.1. Epub 2015 Nov 18.

PMID:
26579944
20.

Internal dosimetry estimates using voxelized reference phantoms for thyroid agents.

Hoseinian-Azghadi E, Rafat-Motavalli L, Miri-Hakimabad H.

J Radiat Res. 2014 May;55(3):407-22. doi: 10.1093/jrr/rrt125. Epub 2013 Nov 11.

Supplemental Content

Support Center